EDGAR Filing Documents for 0001213900-19-016473

Form 8-K - Current report:

SEC Accession No. 0001213900-19-016473

Filing Date

2019-08-21

Accepted

2019-08-21 17:28:58

Documents

Period of Report

2019-08-16

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	CURRENT REPORT	f8k081619_hoththerapeutics.htm	8-K	32787
2	FORM OF SUBSCRIPTION AGREEMENT	f8k081619ex10-1_hoththerap.htm	EX-10.1	250813
3	FORM OF UNIT PURCHASE AGREEMENT	f8k081619ex10-2_hoththerap.htm	EX-10.2	208761
4	FORM OF WARRANT	f8k081619ex10-3_hoththerap.htm	EX-10.3	73903
5	FORM OF REGISTRATION RIGHTS AGREEMENT	f8k081619ex10-4_hoththerap.htm	EX-10.4	162871
6	FORM OF PLACEMENT AGENT WARRANT	f8k081619ex10-5_hoththerap.htm	EX-10.5	85057
7	GRAPHIC	ex10-1_001.jpg	GRAPHIC	5359
	Complete submission text file	0001213900-19-016473.txt		822887

Mailing Address 1 ROCKEFELLER PLAZA, SUITE 1039 NEW YORK NY 10020

Business Address 1 ROCKEFELLER PLAZA, SUITE 1039 NEW YORK NY 10020 551-578-2261

Hoth Therapeutics, Inc. (Filer) CIK: 0001711786 (see all company filings)